Monthly information on share capital and company voting rights
On May 16, 2024, Cellectis released its monthly update on share capital and voting rights as stipulated by Article 223-16 of the French financial markets authority. The company, listed on Euronext Growth under the ISIN code FR0010425595, reported a total of 99,955,535 shares in its capital and 87,891,239 voting rights as of May 3, 2024. For more details, the company provided contact information for their media and investor relations teams.
- Total of 99,955,535 shares in capital indicates strong investor interest and market presence.
- Consistent updates on share capital and voting rights show transparency and regulatory compliance.
- The 87,891,239 voting rights are lower than the total number of shares, indicating possible restrictions or non-voting shares.
(Article 223-16 of General Regulation of the French financial markets authority)
PARIS, May 16, 2024 (GLOBE NEWSWIRE) --
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital | Total number of voting rights |
| 05/03/2024 | 99,955,535 | 87,891,239 |
For further information on Cellectis, please contact:
Media contact:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93, media@cellectis.com
Investor Relations contacts:
Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com
Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577
Attachment
FAQ
What was the total number of shares in Cellectis' capital as of May 3, 2024?
How many voting rights did Cellectis report in May 2024?
What is the ISIN code for Cellectis?
On which market is Cellectis listed?
What regulatory article requires Cellectis to report monthly information on share capital and voting rights?
